InvestorsHub Logo
Followers 21
Posts 1954
Boards Moderated 0
Alias Born 11/14/2018

Re: BonnieMac post# 191387

Wednesday, 11/29/2023 10:30:12 PM

Wednesday, November 29, 2023 10:30:12 PM

Post# of 198709
Now same question with the other sub

Did Virogentics Inc file for patents in their name of the following listed as the company The Company has proprietary technology for producing fully human Monoclonal Antibodies (mAbs) against infectious diseases which is currently being employed to produ


Yes, Virogentics Inc. has filed for patents. The company has proprietary technology for producing fully human Monoclonal Antibodies (mAbs) against infectious diseases. One of their patented and clinically tested compounds is ITV-1 (Immune Therapeutic Vaccine-1), which is a suspension of Inactivated Pepsin Fraction (IPF). This compound is covered by U.S. Patent Nos. 8,066,982 and 7,479,538123. The IPF Technology has been shown to have broad-spectrum antiviral activity, targeting several viruses including influenza, HIV, and herpes simplex virus4. The company is constantly working to improve their IPF Technology and develop new treatments and preventions for viral infections4.

Learn more


1

accesswire.com
2

investorsobserver.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News